By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Incyte Corporation 

Experimental Station
Route 141 & Henry Clay Road, Building E336
Wilmington  Delaware  19880  U.S.A.
Phone: 302-498-6700 Fax: 302-425-2750


Company News
Incyte Corporation (INCY) To Report Fourth Quarter/Year-End 2014 Financial Results On February 12 1/27/2015 11:15:34 AM
Incyte Corporation (INCY) Earns $25 Million Milestone As Jakavi® (ruxolitinib) Recommended For Approval In Europe For Polycythemia Vera 1/23/2015 6:26:50 AM
Incyte Corporation (INCY) Board Appoints Two New Directors 1/9/2015 9:27:48 AM
Agenus (AGEN) To Host Conference Call To Discuss Global Alliance With Incyte Corporation (INCY) Today At 8:30 A.M. EST 1/9/2015 9:24:58 AM
Incyte Corporation (INCY), Agenus (AGEN) Strike $410 Million+ Immuno-Oncology Antibodies Pact 1/9/2015 5:57:01 AM
Incyte Corporation (INCY) To Present At The 33rd Annual J. P. Morgan Healthcare Conference 12/23/2014 8:31:01 AM
Eli Lilly (LLY), Incyte Corporation (INCY) Arthritis Drug Meets Endpoint In Phase 3 12/9/2014 7:27:20 AM
Multiple Data Presentations At The 2014 American Society of Hematology Annual Meeting Showcase Incyte Corporation (INCY)'s Leadership In The Field Of Myeloproliferative Neoplasms (MPNs) 12/2/2014 9:11:25 AM
Incyte Corporation (INCY) To Present At Upcoming Investor Conferences 11/17/2014 5:23:37 PM
Sanofi (SAN.PA) And Incyte Corporation (INCY) Execs Exclusive: Future Hiring Trends And What They're Looking For In New Hires 11/4/2014 9:55:33 AM